exp3174 has been researched along with 2,4-dinitrophenol in 1 studies
Studies (exp3174) | Trials (exp3174) | Recent Studies (post-2010) (exp3174) | Studies (2,4-dinitrophenol) | Trials (2,4-dinitrophenol) | Recent Studies (post-2010) (2,4-dinitrophenol) |
---|---|---|---|---|---|
236 | 29 | 43 | 1,829 | 2 | 254 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benet, LZ; Christians, U; Mutschler, E; Soldner, A | 1 |
1 other study(ies) available for exp3174 and 2,4-dinitrophenol
Article | Year |
---|---|
Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and caco-2 cell monolayers.
Topics: 2,4-Dinitrophenol; Angiotensin II; Animals; Anti-Arrhythmia Agents; Antimetabolites; Biological Transport, Active; Caco-2 Cells; Cell Line; Chromatography, Liquid; Dogs; Energy Metabolism; Epithelium; Humans; Imidazoles; Kidney; Kinetics; LLC-PK1 Cells; Losartan; Mass Spectrometry; Multidrug Resistance-Associated Protein 2; Swine; Temperature; Tetrazoles | 2000 |